InterCure Ltd. (INCR)
3.24
-0.37
(-10.25%)
USD |
NASDAQ |
Nov 05, 14:57
InterCure Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 57.02M |
| November 03, 2026 | 61.51M |
| November 02, 2026 | 61.83M |
| October 30, 2026 | 60.96M |
| October 29, 2026 | 62.60M |
| October 28, 2026 | 66.43M |
| October 27, 2026 | 66.43M |
| October 26, 2026 | 64.24M |
| October 23, 2026 | 67.08M |
| October 22, 2026 | 66.10M |
| October 21, 2026 | 65.88M |
| October 20, 2026 | 65.99M |
| October 19, 2026 | 66.32M |
| October 16, 2026 | 67.52M |
| October 15, 2026 | 68.40M |
| October 14, 2026 | 68.83M |
| October 13, 2026 | 72.55M |
| October 12, 2026 | 71.68M |
| October 09, 2026 | 74.08M |
| October 08, 2026 | 72.55M |
| October 07, 2026 | 73.65M |
| October 06, 2026 | 75.72M |
| October 05, 2026 | 77.15M |
| October 02, 2026 | 76.82M |
| October 01, 2026 | 76.27M |
| Date | Value |
|---|---|
| September 30, 2026 | 75.20M |
| September 29, 2026 | 74.74M |
| September 28, 2026 | 73.21M |
| September 25, 2026 | 74.52M |
| September 24, 2026 | 75.07M |
| September 23, 2026 | 77.36M |
| September 22, 2026 | 76.49M |
| September 21, 2026 | 74.90M |
| September 18, 2026 | 75.61M |
| September 17, 2026 | 75.61M |
| September 16, 2026 | 75.61M |
| September 15, 2026 | 73.65M |
| September 14, 2026 | 75.40M |
| September 11, 2026 | 73.97M |
| September 10, 2026 | 74.85M |
| September 09, 2026 | 74.96M |
| September 08, 2026 | 76.49M |
| September 04, 2026 | 76.82M |
| September 03, 2026 | 75.07M |
| September 02, 2026 | 76.60M |
| September 01, 2026 | 77.80M |
| August 31, 2026 | 80.54M |
| August 28, 2026 | 80.75M |
| August 27, 2026 | 79.66M |
| August 26, 2026 | 82.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IM Cannabis Corp. | 20.14M |
| Raphael Pharmaceutical, Inc. | 30.51M |
| Teva Pharmaceutical Industries Ltd. | 61.66B |
| RedHill Biopharma Ltd. | -11.30M |
| MediWound Ltd. | 157.52M |